whytegirl: I am all in favour of going into phase 2 study for OSTEOARTHRITIS later on this year!
However: HOW will CYNATA finance this on their own? Perhaps they should raise money now whilst their share-price is high? And perhaps even at a higher price-level than CYP is currently trading at...
For the more knowledge-filled ones a question: How much MONEY will that '2 study for osteoarthritis' (approx.) COST and HOW LONG (roughly) will it take until clear results can be seen? TIA !
wasa
Fair Value Please, page-274
-
- There are more pages in this discussion • 196 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
23.5¢ |
Change
0.020(9.30%) |
Mkt cap ! $43.36M | |||
| Open | High | Low | Value | Volume |
| 21.5¢ | 25.0¢ | 21.5¢ | $50.18K | 213.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 13511 | 23.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 25.0¢ | 40000 | 1 |
View Market Depth
| Last trade - 16.10pm 01/10/2024 (20 minute delay) ? |
| CYP (ASX) Chart |